These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 1683526
41. Immunogenicity of recombinant protective antigen and efficacy against intranasal challenge with Bordetella bronchiseptica. Zhao Z, Xue Y, Tang X, Wu B, Cheng X, He Q, Zhang C, Guo A, Jin M, Chen H. Vaccine; 2009 Apr 21; 27(18):2523-8. PubMed ID: 18852008 [Abstract] [Full Text] [Related]
42. Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age. Han WG, van Twillert I, Poelen MC, Helm K, van de Kassteele J, Verheij TJ, Versteegh FG, Boog CJ, van Els CA. PLoS One; 2013 Apr 21; 8(12):e83583. PubMed ID: 24391789 [Abstract] [Full Text] [Related]
43. Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development. Jinyong Z, Xiaoli Z, Weijun Z, Ying G, Gang G, Xuhu M, Quanming Z. Mol Biol Rep; 2011 Mar 21; 38(3):1957-63. PubMed ID: 20878241 [Abstract] [Full Text] [Related]
44. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Peppoloni S, Nencioni L, Di Tommaso A, Tagliabue A, Parronchi P, Romagnani S, Rappuoli R, De Magistris MT. Infect Immun; 1991 Oct 21; 59(10):3768-73. PubMed ID: 1716614 [Abstract] [Full Text] [Related]
45. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. McGuirk P, McCann C, Mills KH. J Exp Med; 2002 Jan 21; 195(2):221-31. PubMed ID: 11805149 [Abstract] [Full Text] [Related]
46. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera. Calver GA, Burton WW, Gardell CY. Can J Microbiol; 1993 Aug 21; 39(8):759-66. PubMed ID: 8106134 [Abstract] [Full Text] [Related]
47. Invasion of human respiratory epithelial cells by Bordetella pertussis: possible role for a filamentous hemagglutinin Arg-Gly-Asp sequence and alpha5beta1 integrin. Ishibashi Y, Relman DA, Nishikawa A. Microb Pathog; 2001 May 21; 30(5):279-88. PubMed ID: 11373122 [Abstract] [Full Text] [Related]
48. Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii. Lee SF, Halperin SA, Knight JB, Tait A. Appl Environ Microbiol; 2002 Sep 21; 68(9):4253-8. PubMed ID: 12200273 [Abstract] [Full Text] [Related]
49. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice. Robinson A, Irons LI. Infect Immun; 1983 May 21; 40(2):523-8. PubMed ID: 6301999 [Abstract] [Full Text] [Related]
51. A Bordetella pertussis acellular vaccine candidate: antigenic characterization and antibody induction. Dias WO, Horton DS, Takahashi CM, Raw I. Braz J Med Biol Res; 1994 Nov 21; 27(11):2607-11. PubMed ID: 7549983 [Abstract] [Full Text] [Related]
52. Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals. Walker MJ, Guzmán CA, Rohde M, Timmis KN. Infect Immun; 1991 May 21; 59(5):1739-46. PubMed ID: 1708358 [Abstract] [Full Text] [Related]